Dr Reddys Laboratories Share Price Today - Live Blog for October 29, 2025

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.07% gain, with the share price now at ₹1,258.50. Notably, the stock's PE ratio stands at 18.7700, and its Return on Equity (ROE) is 16.0277%.

After a significant 0.51% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,259.25 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.92% increase in its share price and is currently trading at ₹1,252.00. This remarkable performance has caught the eye of investors.

After a -1.58% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,240.05. The stock has a PE ratio of 18.7700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.46% gain, with the share price now at ₹1,258.20. Notably, the stock's PE ratio stands at 18.7700, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd's share price has fallen by -0.44%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,254.85, and market participants are assessing the implications. The stock has a PE ratio of 18.7700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.44%, reaching a current market price of ₹1,254.85. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd suffered a -0.44% drop, and it's now trading at ₹1,254.85 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price has fallen by -0.44%, a situation worth noting. At present, the stock is trading at ₹1,254.85. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.7700, while the industry PE ratio is 34.8555.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,286.50. The stock has a PE ratio of 18.7700, an ROE of 16.0277%, and a debt to equity ratio of 0.1625.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,286.50. The stock has a PE ratio of 18.7700, an ROE of 16.0277%, and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at ₹1,287.90. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd stock price decreased by -0.03%, with the current market value at ₹1,285.95 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's stock price surged by 0.11%, reaching the current market value of ₹1,286.40 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd experienced a -0.10% downturn in its share price, and it's currently trading at ₹1,286.80. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's share price has dropped by -0.17%, a development that warrants careful analysis. Presently trading at ₹1,287.15, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.07%, reaching a current market price of ₹1,289.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.10% boost, with the current market value at ₹1,290.35 per share. This surge has not gone unnoticed by investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.10%. At this moment, it's actively trading at ₹1,290.35, presenting an enticing opportunity for those in the market.

With a -0.36% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,284.05. Investors should examine the factors driving this decline. The stock's PE ratio is 18.7700, whereas the industry PE ratio stands at 34.8555.

Dr Reddys Laboratories Ltd stock price decreased by -0.49%, with the current market value at ₹1,288.15 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd experienced a -0.17% dip in its share price and is currently trading at ₹1,287.05. The stock has a PE ratio of 18.7700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price has declined by -0.17%, and it's currently trading at ₹1,287.05. The stock maintains a PE of 18.7700, while the industry PE is 34.8555, prompting discussions about its valuation.

With a -0.21% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,287.40. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.7700, while the industry PE is 34.8555.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.07% increase and currently trading at ₹1,290.40 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's share price rallied by 0.07%, reaching the current market price of ₹1,290.40. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.07%, signalling a challenging period. Currently trading at ₹1,289.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd witnessed a -0.60% decrease in its share price, and it is currently trading at ₹1,289.90. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.7700, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.61% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,298.90 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.